Goliath vs Goliath: All eyes on Wesfarmers (ASX:WES) share price as conglomerate vows to vote against Woolies

Two strong women battle it out in the ring.

The Wesfarmers Ltd (ASX: WES) share price is on watch on Wednesday after the company reiterated its intent to win Australian Pharmaceutical Industries Ltd (ASX: API), despite facing major competition.

Woolworths Group Ltd (ASX: WOW) recently entered the battle to take over the Priceline owner, outbidding Wesfarmers by more than $100 million.

Today, Wesfarmers reminded the market of its 19.3% holding in API and vowed to vote its stake against the supermarket giant’s takeover.

As of yesterday’s close, the Wesfarmers share price is $58.41.

Let’s take a closer look at today’s announcement from the company.

All eyes on the Wesfarmers share price

The Wesfarmers share price is in the spotlight this morning after the company announced it won’t back down from its attempt to acquire API despite Woolworths’ $872 million bid.

Wesfarmers states it believes its own $763 million bid is a superior proposal and confirmed it will be voting its shareholding, and “any other API shares that it may acquire” against the competitor.

The company also said its takeover will “significantly benefit community pharmacists and Priceline franchisees.”

That might be a jab at Woolworths after the Pharmacy Guild of Australia questioned the company’s intentions. In a statement, a Guild spokesperson asked:

Why is a company with interests in the alcohol, tobacco, gambling, and nightclub industries wanting to move into healthcare?

In today’s release, Wesfarmers managing director Rob Scott said:

[W]e’re confident our proposal supports community pharmacists and their businesses, for the long-term. Pharmacists face various competitive pressures and Wesfarmers is uniquely placed to support the growth of community pharmacies including Priceline franchisees.

Additionally, the company addressed potential data privacy issues.

Key stakeholders apparently voiced concerns that data from Priceline’s Sister Club might be shared with Wesfarmers’ 50%-owned Flybuys loyalty program. Flybuys is co-owned by Coles Group Ltd (ASX: COL), which was demerged from Wesfarmers in 2018.

The worries were due to an overlap of non-prescription products sold in both supermarkets and pharmacies.

However, Wesfarmers assures it will keep API data entirely separate from all supermarket-based loyalty programs. It noted:

This assurance provides API and its community pharmacists, including current and future Priceline franchisees, with comfort that their customer data will be protected from supermarket competitors.

Right now, the Wesfarmers share price is 13.4% higher than it was at the start of 2021. Though, it’s only gained 0.7% since it posed its takeover offer to API in July.

The post Goliath vs Goliath: All eyes on Wesfarmers (ASX:WES) share price as conglomerate vows to vote against Woolies appeared first on The Motley Fool Australia.

Should you invest $1,000 in Wesfarmers right now?

Before you consider Wesfarmers, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended COLESGROUP DEF SET and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3IT9yr6

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *